Clinical Trials Sponsored by Duke Cancer Institute

Total 29321 results

Duke University
Duke Cancer Institute

Completed

Feasibility and Smokers' Reactions to DNA Feedback

Smoking

United States
Duke University
Duke Cancer Institute

Completed

Mindfulness Meditation in Glioma Patients

Malignant Glioma

United States
Duke University
Duke Cancer Institute

Completed

Using a Geriatric Oncology Assessment to Link With Services (GOAL)

Cancer

United States
Duke University
Duke Cancer Institute

Completed

Endometrial Cancer Diet and Exercise

Early Stage Endometrial Cancer

United States
Duke University
Duke Cancer Institute

Completed

Early Palliative Care Intervention in Malignant Glioma

Malignant Glioma

United States
Duke Cancer Institute
National Cancer Institute (NCI)

Completed

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Colorectal Cancer | Metastatic Cancer

United States
Duke University
Millennium Pharmaceuticals, Inc.; Duke Cancer Institute

Terminated

Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
Gary Archer Ph.D.
National Cancer Institute (NCI); Duke Cancer Institute

Terminated

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM (INTERCEPT)

Recurrent Glioblastoma | Recurrent Gliosarcoma

United States
Duke University
National Cancer Institute (NCI)

Completed

Smokeless Tobacco Cessation Intervention for Firefighters

Smokeless Tobacco Cessation

United States
Duke University
National Cancer Institute (NCI)

Completed

Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Survival TRaining for ENhancing Total Health (STRENGTH)

Depression | Breast Cancer | Weight Changes

United States
Duke University
National Cancer Institute (NCI)

Completed

Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer

Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer

Depression | Breast Cancer | Fatigue | Malnutrition | Prostate Cancer | Psychosocial Effects of Cancer and Its Treatment

United States
Duke University
National Cancer Institute (NCI)

Completed

EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
Duke University
National Cancer Institute (NCI)

Withdrawn

A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Recurrent Adult Brain Tumor

United States
Duke University
National Cancer Institute (NCI)

Terminated

Stereotactic Radiosurgery in Treating Patients With Brain Metastases

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors

Brain and Central Nervous System Tumors | Neuroblastoma

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Brain Metastases

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Sarcoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Childhood Germ Cell Tumor

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Esophageal Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

Kidney Cancer

United States
Duke University
National Cancer Institute (NCI)

Withdrawn

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Lymphoma | Leukemia

United States
Duke University
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Brain and Central Nervous System Tumors | Metastatic Cancer | Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Brain and Central Nervous System Tumors

United States
Duke University
Pfizer; National Comprehensive Cancer Network; Duke Cancer Institute; Pillars4Life...

Completed

Four Conversations RCT

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Recruiting

Adolescents and Young Adults (AYAs) With Advanced Cancer

Adolescent and Young Adult Cancer Patient

United States
Duke University
National Cancer Institute (NCI)

Terminated

Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions

Newly Diagnosed Cancer Patients Who Are HIV Positive and Their Treating Oncologist

United States
Duke University
National Cancer Institute (NCI)

Terminated

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention

Smokeless Tobacco Cessation

United States
Duke University
National Cancer Institute (NCI)

Completed

Improving Adherence to Recommended Surveillance in Breast Cancer Survivors

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer

Malnutrition | Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight

Breast Cancer | Colorectal Cancer | Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Terminated

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Lymphoma | Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Mila Blooms Intervention Study

Childhood Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Duke University
National Cancer Institute (NCI)

Terminated

Immunotherapy in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Erectile Dysfunction Study

Erectile Dysfunction

United States
Duke University
National Cancer Institute (NCI)

Completed

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking (Parejas)

Smoking Cessation

United States

Clinical Trials Sponsored by Duke Cancer Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations